SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-021427
Filing Date
2023-06-15
Accepted
2023-06-15 16:10:48
Documents
14

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 2604899
2 form424b3_001.jpg GRAPHIC 9359
3 form424b3_002.jpg GRAPHIC 41228
4 form424b3003.jpg GRAPHIC 23713
5 form424b3_004.jpg GRAPHIC 29705
6 form424b3_005.jpg GRAPHIC 9734
7 form424b3_006.jpg GRAPHIC 25106
8 form424b3_007.jpg GRAPHIC 11793
9 form424b3_008.jpg GRAPHIC 15893
10 form424b3_009.jpg GRAPHIC 10302
11 form424b3_010.jpg GRAPHIC 12383
12 form424b3_011.jpg GRAPHIC 31331
13 form424b3_012.jpg GRAPHIC 18080
14 form424b3_013.jpg GRAPHIC 5713
  Complete submission text file 0001493152-23-021427.txt   2943920
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 424B3 | Act: 33 | File No.: 333-272005 | Film No.: 231017439
SIC: 2836 Biological Products, (No Diagnostic Substances)